Opinions Norman Levine
Cascades IncCAS.TOCOMMENTJun 17, 2016
Stock price when the opinion was issued
As of Jun 10, 2026. Market Open.
You might be interested:
Huge new facility is coming onstream, and fundamentals in containerboard are more solid than in the very competitive tissue market. Facility over budget, so will take a while to get a return. Focused on debt reduction.
Michael Sprung
Likes it, though shares have been down the past year. They fixed their operational issues. Demand remains strong in container board, and they opened a facility in Virginia which could raise margins. They sold their European division, so are more streamlined in operations. Pays around a 4% dividend. Still likes it.
Michael SprungThey've been hit by a lot of input costs, which may be easing now. It's hard to raise prices on tissue paper and costs have been rising on recycled fibre. Their new container board factory will operate soon. CAS is selling at the low end of its range historically. But be patient until the stock price doubles or even triples.
(Analysts’ price target is $9.83)
Michael Sprung;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium content
Michael SprungMichael SprungPremium contentMichael Sprung
Bill Harris, CFAMichael SprungMichael Sprung
Robert McWhirter
A wonderfully run company with great assets. The problem is that they are full of debt. Until they pay off a lot of their debt, he is afraid to go near them. They are in 2 main businesses, tissues such as toilet paper and hand tissues as well as container and cardboard. This part is not economically sensitive and is mostly private label. The other side is box board and container board, packaging, which is much more economically sensitive.